# Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole

> **NCT02234570** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 70 (actual)

## Conditions studied

- Neurocysticercosis

## Interventions

- **DRUG:** Oxfendazole
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02234570
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-17
- **Primary completion:** 2015-11-24
- **Final completion:** 2015-11-24
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2020-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02234570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02234570, "Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02234570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*